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ABSTRACT The mammalian protooncogene homologue
of the avian v-ets sequence from the E26 retrovirus consists of
two sequentially distinct domains located on different chromo-
somes. Using somatic cell hybrid panels, we have mapped the
mammalian homologue of the 5' v-ets-domain to chromosome
11 (ETSI) in man, to chromosome 9 (Ets-1) in mouse, and to
chromosome D1 (ETSI) in the domestic cat. The mammalian
homologue of the 3' v-ets domain was similarly mapped to
human chromosome 21 (ETS2), to mouse chromosome 16
(Ets-2), and to feline chromosome C2 (ETS2). Both proto-
oncogenes fell in syntenic groups of homologous linked loci that
were conserved among the three species. The occurrence of two
distinct functional protooncogenes and their conservation of
linkage positions in the three mammalian orders indicate that
these two genes have been separate since before the evolution-
ary divergence of mammals.
Transforming genes, or protooncogefles, represent a class of
conserved cellular genes that may play an important role in
tumorigenesis. They were initially described as transduced
RNA segments in transforming retrovirus genomes, and they
have also been discovered by focus induction after
transfection of mouse 3T3 cells with genomic DNA extracted
from human tumors (1-5). The limited number of proto-
oncogenes (%30) described to date has attracted considerable
research emphasis as an experimental opportunity to study
neoplastic transformation from both genetic and molecular
perspectives. Because of these extensive analyses, there are
now at least five documented modes of oncogene activation
associated with tumorigenesis. These include the following:
(i) transduction of portions of protooncogene transcripts by
retroviruses, thereby placing the oncogene under regulatory
control of strong promoters in the viral long terminal repeats
(1-5); (ii) chromosomal insertion of an infecting retrovirus
adjacent to a protooncogene, similarly altering their control
of transcription (5, 6); (iii) translocation of cellular oncogenes
to chromosomal regions of differential regulation (7, 8); (iv)
amplification of oncogene-containing segments, thereby in-
creasing the dosage of the oncogene (9-11); and (v) point
mutation in the cellular coding sequence (2).
The ets sequence was identified as a second cellular
sequence transduced by the avian replication-defective ret-
rovirus E26. The 5.7-kilobase (kb) RNA genome of E26
contains, in addition to partial retroviral gag and env genes,
a part of the myb oncogene originally identified in avian
myeloblastosis virus (AMV) and an E26-specific sequence,
ets (12, 13). The nucleotide sequence of a 2.46-kb DNA
region of E26 has revealed a contiguous gag-myb-ets open
reading frame encoding a 135-kDa protein, p135 (14, 15). E26
induces both myeloblastosis and erythroblastosis in vivo and
transforms erythroid and myeloid precursors in vitro. The
myeloid oncogenic properties that E26 and AMV have in
common are thought to be encoded by the common myb
domain, while the unique erythroblastosis of E26 is thought
to be encoded by the unique ets domain of the tripartite viral
onc gene (14, 16) or perhaps by a cooperative effect of myb
and ets. We have prepared a series of molecular clones of the
human ets sequence and discovered that the coding sequence
is disrupted in the human genome, where two sequentially
distinct, transcriptionally active, and chromosomally sepa-
rate loci encode homologues of the 5' and 3' regions of the
avian viral oncogenes (17). We report here the chromosomal
localization of the 5' locus (termed ets-)) and the 3' locus
(termed ets-2) in three mammals: human, mouse, and cat.
Their chromosomal positions in each species reside on
homologous (syntenic) chromosomal segments, indicating
that the two domains of the ets protooncogene have been on
separate chromosomes since before the onset of the mamn-
malian radiations.
MATERIALS AND METHODS
Use of Panels of Somatic Cell Hybrids for Chromosome
Mapping of Human, Murine, and Feline Genes. Somatic cell
hybrids were derived by PEG-mediated fusion of fresh
human lymphocytes to rodent cells (mouse RAG or Chinese
hamster E36) lacking the hypoxanthine/guanine phosphori-
bosyltransferase (HPRT) gene, thus allowing selection in
hypoxanthine/aminopterin/thymidine medium. A panel of
60 hybrids was selected based on the high frequency of
retention oflow numbers ofhuman chromosomes in different
combinations (18-20). Hybrids were genetically character-
ized by G-trypsin banding (21), G-11 staining, and enzyme
typing of 20-28 isozyme markers previously assigned to
human chromosomes at the same passage from which high
molecular weight DNA was extracted (20). Genomic DNA
was digested with restriction enzymes and subjected to a
Southern analysis (22) using the specific v-ets, ets-1, and ets-2
probes described below (15, 17). Analogous procedures were
used to prepare and characterize the rodent-feline hybrid
panel, which segregates cat chromosomes (23), and the
Chinese hamster-mouse panel, which segregates mouse
chromosomes (24).
Abbreviation: kb, kilobase(s).
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Identification ofHuman Cellular ets-Related DNA with v-ets,
c-ets-1 and c-ets-2 Molecular Clones as Probes. E.1.28 is a
1.28-kb v-ets clone derived by Bgl I digestion of pER4, a
molecular clone ofthe E26 provirus (15). E.1.28 contains 95%
of the viral ets sequence (v-ets). Three human genomic
clones that discriminate between c-ets-1 and c-ets-2 were
used. The first two, pRD6K and pRD700, are human frag-
ments derived from a single phage clone, RD3. pRD6K is a
5.7-kb EcoRI fragment; pRD700 is an 0.83-kb EcoRI frag-
ment. Both pRD6K and pRD700 recognize human c-ets-J.
The third human probe, H33, is a 1.02-kb EcoRI fragment
that is specific for human c-ets-2. The three human clones
share sequence homology with different regions of the viral
ets sequence. From 5' to 3', the relative order in ets of
homologous sequences is pRD6K-pRD700-pH33 (17).
RESULTS
Human Protooncogene ETS1 Maps to Chromosome 11 and
ETS2 Maps to Chromosome 21. To identify the human
protooncogene homologues of v-ets, a nearly full-length v-ets
molecular clone, E.1.28 (Fig. 1A), was nick-translated and
used as a probe on nitrocellulose filters derived from a
Southern analysis (22) of human and rodent DNAs. Frag-
ments of 8.2, 6.2, 3.6, and 0.83 kb were detected following
EcoRI digestion ofhuman DNA (Fig. L4). The segregation of
three of these fragments (8.2, 6.2, and 3.6 kb) was examined
using DNAs from a panel of 50 somatic cell hybrids that had
been genetically characterized by electrophoretic typing of
previously assigned isozyme loci and by karyotype analysis
using both G-11 and G-trypsin staining procedures (20, 21,
23). These hybrids, which were prepared by PEG-mediated
fusion of normal human lymphocytes with HPRT-resistant
mouse (RAG) or Chinese hamster (E36) fibroblasts, retained
the entire rodent genome but lost human chromosomes in
different combinations.
Two of the human c-ets fragments produced by EcoRI
digestion (6.2 and 8.2 kb) were concordantly retained or lost
in the hybrid panel. The 3.6-kb fragment segregated inde-
pendently of the others (Fig. LA), suggesting that at least two
chromosomes contained sequences homologous to v-ets.
This result has been confirmed by the molecular cloning of
two ets genes, the characterization and DNA sequences of
which are discussed in detail elsewhere (17). These studies
have shown that distinct human loci are homologous to the 5'
and 3' regions of the v-ets oncogene sequence. The two genes
are both transcriptionally active, since they produce mRNA
species of different sizes in several tissues (17).
Subclones of human DNA sequences homologous to dif-
ferent portions of the v-ets gene were used in the mapping
experiments. Clone H33, which is homologous to the 3'
portion of v-ets, hybridized to the 3.6-kb human EcoRI
fragment but not to the 0.83-, 6.2-, or 8.2-kb fragments (Fig.
1B). Two additional cloned human sequences, pRD6K and
pRD700, were shown to be homologous to contiguous 5'
portions of v-ets. These probes recognized the EcoRI frag-
ments of 6.2 and 0.83 kb, respectively, but did not cross-
hybridize with clone H33. The human DNA segment homol-
ogous to the 5' regions of v-ets, which is characterized by the
0.83/6.2-kb EcoRI pattern, is referred to as c-ets-1. The
human locus homologous to the 3' region of v-ets, for which
the 3.6-kb EcoRI fragment is diagnostic, is termed c-ets-2.
The chromosomal positions of ets-J and ets-2in the human
genome were determined by correlating the presence of the
diagnostic EcoRI fragments in the hybrid panels using both
clone E.1.28 (v-ets) and clone H33 (ets-2-specific) as probes.
The presence of the ets-J locus was 92-97% concordant with
human chromosome 11 and the chromosome 11 isozyme
markers LDHA and ACP2 but was highly discordant
(33-58%) with each of the other human chromosomes (Fig.
2). The presence of ets-2 was 100% concordant with the
presence of human chromosome 21 and its isozyme marker,
SOD] (Fig. 2B). These data document that the ets-J
protooncogene is located on chromosome 11 and that the
ets-2 locus is on chromosome 21. The assignment of ets-J to
chromosome 11 is consistent with the recent study of de
Taisne et al. (25), who reported the assignment of an ets
protooncogene to 11q23-24.
In situ hybridization of clone H33 (ets-2 specific) clone to
normal human chromosome preparations confirmed the as-
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FIG. 1. Analysis of human ets-1 and ets-2. Restriction maps of the avian provirus and of clone H33 (c-ets-2 specific) are presented below
the corresponding autoradiographs. -, ets-specific sequences (14, 17). (A) DNAs from mouse-human (70 series) and Chinese hamster-human
(80 and 81 series) somatic cell hybrids were digested with EcoRI and probed with a molecular clone of the avian v-ets gene (E.1.28). (B) The
gels were then washed and probed with H33, a molecular clone of the human c-ets-2 homologue that recognizes the 3.6-kb fragment but not
the 0.83-, 6.2-, and 8.2-kb fragments that are diagnostic for c-ets-1. o, Pvu II; , HindIII; 1, Bgl I; *, Bgl II; 6, Pst I; ., Hph I; 0, EcoRI;
r, Xba I; t, Taq I. bp, Base pairs. (C) Distribution of 37 grains that fell on human chromosome 21 in 89 metaphase spreads after in situ
hybridization using H33 (ets-2 specific) as a probe.
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FIG. 2. Analysis ofthe association of ets-) and ets-2 diagnostic fragments with segregant chromosomes in three panels of somatic cell hybrids.
The human panel consists of 40 hybrids (18, 19); the murint panel, 16 hybrids (24); and the feline panel, 38 hybrids (21, 23). Chromosome scores
represent the consensus result of karyotyping (G-banding) and isozyme scores. Thirty-six isozyme systems diagnostic for human chromosomes
and 24 systems diagnostic for feline chromosomes were tested for each appropriate hybrid. Assignment of feline LDH1A (lactate
dehydrogenase-1) and ACP2 (acid phosphatase-2) to feline chromosome D1 is a corrected assignment (S.J.O'B. et al., unpublished data).
signment of ets-2 to chromosome 21 and further localized the
gene to the long arm (Fig. 1C). In an analysis of 89 metaphase
spreads from normal human peripheral blood cells, 37 grains
were found located on chromosome 21; 34 of these were
located on the terminal portion. These labeled sites, each
consisting of 1-3 grains, represented 20% (20 out of 100) of all
labeled sites distributed throughout the 89 metaphase
spreads. Compilation ofgrain positions from multiple (n = 50)
labeled chromosomes 21 revealed a clustering of grains on
segments 22.1-22.3. On the basis of a significant labeling of
this region on the long arm of chromosome 21, we conclude
that the ets-2 gene is regionally located on human chromo-
some 21q22.1-22.3.
Assignment of Mouse Ets-) to Chromosome 9 and Ets-2 to
Chromosome 16. The murine homologues of v-ets were
visualized as three fragments with EcoRI (5.1, 6.8, and 15 kb;
Fig. LA) and with Pst I (2.9, 7.8, and 9.8 kb, Fig. 3) using both
the v-ets (E.1.28) and the ets-2 (H33) clones as probes. The
ets-1-specific pRD700 probe described above recognized
only the 3.2-kb HindIII fragment (data not shown). The ets-2
specific human probe (H33) recognized both ets-1 and ets-2
murine homologues for reasons that were not immediately
apparent. Nonetheless, the homology of H33 to the ets-1
locus in the mouse permitted the use of this probe in tracking
the gene segregation in somatic cell hybrids. A previously
characterized panel ofmouse-Chinesehamster (E36) hybrids
was used to study chromosome association of the murine ets
loci (24). These hybrids retain the entire Chinese hamster
chromosomal complement but lose mouse chromosomes in
different combinations. DNA was extracted from each of 16
hybrids concomitant with isozyme and karyologic analyses to
determine the murine chromosome complement.
The murine DNA fragments segregated as two distinct loci
in the hybrid panel (Fig. 3). The Pst I fragment that is
diagnostic for Ets-1 (7.8 kb) was 94% concordant with mouse
chromosome 9 but discordant with the Ets-2 (2.9 and 9.8 kb)
segments and with each of the 19 other mouse chromosomes
(30-70%; Fig. 2). The 2.9-kb segment diagnostic forEts-2 was
(D - N N C C Ca' v E =
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FiG. 3. Analysis of murine Ets-1 and Ets-2 in mouse-Chinese
hamster somatic cell hybrids. Hybrid DNA was digested with Pst I
and hybridized with a probe prepared for the human cellular clone
H33, which is specific for ets-2 in man but hybridizes to ets-) and
ets-2 fragments in mouse. Hybrid DNA was also digested with
HindIll and hybridized with the human genomic pRD700 molecular
clone, specific for ets-).
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94% concordant with mouse chromosome 16 and highly
discordant (Fig. 2) with Ets-1 (37%) and the 19 other mouse
chromosomes (25-60%). In addition, one of the hybrids
positive for Ets-2 contained no other mouse chromosomes
except for chromosome 16. These data permit assignment of
Ets-1 and Ets-2 to murine chromosomes 9 and 16, respec-
tively.
The assignment of ets-2 to chromosome 21 in man and
chromosome 16 in mouse represents the fifth homologous
locus assigned to both of these chromosomes in the two
species (26). The map distance involved in this homologous
syntenic group was determined by a linkage analysis between
the Sod-i and ets-2 loci using restriction fragment length
polymorphisms between inbred mouse strains. Briefly, DNA
from several inbred mouse strains was examined with 14
restriction enzymes and two molecular probes: (i) an ets-2-
specific 1.27-kb Pst I fragment that was homologous to H33
(Fig. lA) derived from a murine genomic library and (ii) a
4.1-kb cloned fragment containing the fifth exon ofthe human
SOD] gene plus part of the 5' intron and 3' flanking DNA
(kindly provided by Yoram Groner). The murine ets-2 probe
detected fragments of 9.4 kb in BALB/cJ and 17 kb in CBA/J
DNAs after digestion with BamHI. The CBA mouse strain
displays a 4.4-kb BstEII fragment when probed with the
human SOD] clone, while BALB/c has a 2.1/2.3-kb doublet
with this restriction enzyme. F1 hybrid females (CBA x
BALB/c) were mated to BALB/c males and DNAs from 40
offspring were analyzed with the two probes. Thirty-eight of
the offspring received the parental combination of Ets-2 and
Sod-i alleles from their F1 parent (20 were BALB/c type, 18
were CBA type) and two were recombinant. These results
confirm the assignment ofEts-2 to mouse chromosome 16 and
establish the linkage distance between Ets-2 and Sod-i as 5.0
± 1.4 centimorgan units.
Assignment of Feline ETS1 to Chromosome D1 and ETS2 to
Chromosome C2. The domestic cat homologues of the viral
ets sequence were resolved following digestion of genomic
DNA with Xba I and hybridization with one of two probes:
(i) H33, specific for c-ets-2, and (ii) pRD700, specific for
c-ets-1. The somatic cell hybrid panel used for the cat
mapping was expanded and analyzed for chromosomal com-
plement by the same strategies used in the human analysis
(21, 23).
Two Xba I fragments (6.8 and 11.0 kb) were detected in cat
DNA and these segregated independently in the hybrid panel
(Fig. 4). As with the mouse homologues, both fragments were
resolved with the H33 (human ets-2 specific) probe. The
pRD700 probe, which is specific for human ets-1, preferen-
tially detected the 4.0-kb band. This fragment was 96-100%
concordant with feline chromosome D1 and its included
markers LDHA, and ACP2 (Fig. 2), but highly discordant
(18-47%) with the 18 additional feline chromosomes. The
appearance of the 11.0-kb Xba I feline fragment in the panel
was 93-100% concordant with the presence of chromosome
C2 and its isozyme markers, SOD] and GSR (glutathione
reductase) but highly discordant (25-70%o) with other cat
chromosomes. These data permit assignment of the ets-1 cat
homologue to chromosome D1 and ofthe ets-2 cat homologue
to chromosome C2.
DISCUSSION
At least three different prototype transforming retroviruses
have been described that contain two distinct oncogenes
encompassed by helper viral sequences. These include the
avian carcinoma virus MH2, which contains v-myc and v-mht
(also called mil; raf); avian erythroblastosis virus, which
contains v-erbA and v-erbB; and the E26 virus, which
contains v-myb and v-ets. We have reported here that the
v-ets segment of E26 is derived from two domains that are
themselves encoded on different chromosomes in mammals.
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FIG. 4. Analysis of feline ets-1 and ets-2 in hamster-cat somatic
cell hybrids. Hybrid DNAs were digested with Xba I and hybridized
with the human H33 probe, which is specific for ets-2 in man but
hybridizes to both ets-1 and ets-2 fragments in cat and mouse.
Hamster-feline hybrids were also digested with Xba I and hybridized
with the human pRD700 probe, which is specific for ets-1 in man,
mouse, and cat.
In addition to E26, two oncogenic viruses, Gardner-Rasheed
feline sarcoma virus (GR-FeSV) and FBR murine sarcoma
virus (FBR-MuSV), contain hybrid onc genes that include
genetic elements from two different cellular genes and from
essential retrovirus genes (27-29). Diagnostic genomic clone
probes for the two domains (termed ets-1 and ets-2) have
been used to demonstrate transcriptional activity ofboth loci
(17) and to chromosomally map the homologues in this study.
The genes overlap in a stretch of 14 amino acids in man (17)
and have been assigned to chromosomes 11 and 21, respec-
tively.
This dispersal of mammalian proto-ets sequences is in
apparent contrast to organization in the chicken, from which
the E26 virus was originally isolated. Avian c-ets has a
genomic complex of 40-50 kb (15) that encodes a 7.5-kb ets
mRNA (13, 17). This single RNA transcript is resolved in
RNA blots with both ets-1- and ets-2-specific probes, sug-
gesting that the two domains are contiguous in the chicken
genome. The biologically active viral ets mRNA is a trun-
cated 1.5-kb version of the chicken message. Since v-ets is a
rather small subset of the chicken proto-ets locus, as well as
of the two mammalian c-ets loci, the relative contributions of
the myb, ets-1, and ets-2 domains to viral transformation are
not obvious.
With the recent rapid expansion of the human, murine, and
feline gene maps, a more complete picture of chromosomal
homologies between these species is emerging (30). More
than 100 homologous genes have been mapped in both mouse
and man, and comparison of the two gene maps has revealed
that considerable rearrangement has occurred since these
species shared a common ancestor (26, 30, 31). The cat has
fewer mapped loci than the mouse, but the extent ofretention
of homologous syntenic groups to man seems to be two to
three times greater than between man and rodents (23, 30).
The ets-1 locus is mapped here to chromosome llq in man,
to the chromosome 11 homologue in the cat (D1), and to the
murine homologue of llq (chromosome 9). Fig. 5 shows the
homologous loci mapped to the respective linkage groups in
the three species. The ets-2 locus mapped to human chro-
mosome 21, to the murine counterpart chromosome 16, and
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FIG. 5. Diagram of regional positions of homologous loci on
chromosomes to which ets-1 and ets-2 have been assigned in man,
mouse, and cat. All of the loci have been regionally assigned in the
human map and several have been positioned in mouse. The figure
is modified from genetic maps of man (32), mouse (33), and cat (34).
The basis for homology of the genes included is discussed in refs. 26
and 30.
to the feline homologue, chromosome C2. The conservation
of the linkage position of the two protooncogene domains in
the same chromosomal positions in the three species indi-
cates that their duality has persisted since the divergence of
mammals began more than 100 million years ago.
Because the occurrence of specific translocations in human
tumorigenesis has been shown to alter the cis regulation of
adjacent protooncogene loci, the specific positions of such
loci may be important. The same chromosome region that
contains human ets-1 (11q23-24) has been reported to be
involved in nonspecific translocations in acute myelogenous
leukemia, as well as in Ewing sarcoma (25, 35, 36). The
localization of ets-2 represents the first potential onc se-
quence mapped to chromosome 21. It may be noteworthy
that trisomy 21 or Down syndrome patients have an elevated
incidence of acute leukemias. Since the region implicated (37,
38) as operative in Down syndrome (21q22) includes the ets-2
sequence (21q22.1-22.3), dosage aneuploidy of this gene
should be considered as a candidate for a physiological role
in the development of Down syndrome. Furthermore, this
same region of chromosome is involved in a specific
translocation (8;21)(q22;q22) commonly found in acute
myelogenous leukemia with morphology M2 (39, 40). Pre-
liminary results from our laboratory show that certain human
acute myeloid leukemias with translocated chromosomes 11
or 21 show altered transcriptional expression of ets-l and
ets-2, respectively (41). (For consistency with the nomencla-
ture for other human and feline genes, the sequences referred
to here as c-ets-J and c-ets-2 should be identified as ETS1 and
ETS2, respectively).
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